← Open Payments lookup

ROBIN DIBIASE: Open Payments

NPI 1255915716 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,611 in 76 payments from 30 companies in 2025. Trend: 2023 $1,386 · 2024 $1,244 · 2025 $1,611

Food & beverage: $1,531Education: $80
CompanyPaymentsAmount
Janssen Biotech, Inc.8$204
Exelixis Inc.9$191
Novartis Pharmaceuticals Corporation11$177
GlaxoSmithKline, LLC.4$104
Daiichi Sankyo Inc.5$97
AstraZeneca Pharmaceuticals LP4$77
E.R. Squibb & Sons, L.L.C.3$54
Syndax Pharmaceuticals, Inc.2$52
Boehringer Ingelheim Pharmaceuticals, Inc.2$51
Merck Sharp & Dohme LLC2$49

Products named: CABOMETYX, DARZALEX, KISQALI, OJJAARA, Enhertu, KEYTRUDA, SCEMBLIX, OPDIVO.

Industry payments across CA — which companies pay providers there.